Next Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $742K | Buy |
38,560
+5,793
| +18% | +$111K | 0.05% | 397 |
|
|
2021
Q3 | $682K | Buy |
32,767
+2,836
| +9% | +$59K | 0.05% | 365 |
|
|
2021
Q2 | $642K | Buy |
29,931
+2,403
| +9% | +$51.5K | 0.05% | 375 |
|
|
2021
Q1 | $543K | Buy |
27,528
+710
| +3% | +$14K | 0.05% | 395 |
|
|
2020
Q4 | $530K | Buy |
26,818
+2,722
| +11% | +$53.8K | 0.05% | 355 |
|
|
2020
Q3 | $424K | Buy |
24,096
+1,526
| +7% | +$26.9K | 0.05% | 370 |
|
|
2020
Q2 | $405K | Buy |
22,570
+774
| +4% | +$13.9K | 0.05% | 335 |
|
|
2020
Q1 | $327K | Buy |
21,796
+3,169
| +17% | +$47.5K | 0.04% | 376 |
|
|
2019
Q4 | $325K | Buy |
18,627
+4,600
| +33% | +$80.3K | 0.03% | 496 |
|
|
2019
Q3 | $212K | Buy |
14,027
+225
| +2% | +$3.4K | 0.02% | 651 |
|
|
2019
Q2 | $233K | Buy |
+13,802
| New | +$233K | 0.03% | 608 |
|
|
2017
Q3 | – | Sell |
-1,032
| Closed | -$22K | – | 1841 |
|
|
2017
Q2 | $22K | Buy |
1,032
+19
| +2% | +$405 | 0.01% | 1037 |
|
|
2017
Q1 | $21K | Sell |
1,013
-617
| -38% | -$12.8K | 0.01% | 1031 |
|
|
2016
Q4 | $28K | Buy |
1,630
+36
| +2% | +$618 | ﹤0.01% | 1213 |
|
|
2016
Q3 | $30K | Buy |
1,594
+660
| +71% | +$12.4K | 0.01% | 1175 |
|
|
2016
Q2 | $16K | Sell |
934
-135
| -13% | -$2.31K | 0.01% | 1043 |
|
|
2016
Q1 | $19K | Hold |
1,069
| – | – | 0.01% | 955 |
|
|
2015
Q4 | $25K | Buy |
1,069
+192
| +22% | +$4.49K | 0.01% | 852 |
|
|
2015
Q3 | $19K | Buy |
877
+18
| +2% | +$390 | 0.01% | 965 |
|
|
2015
Q2 | $24K | Buy |
859
+15
| +2% | +$419 | 0.01% | 928 |
|
|
2015
Q1 | $23K | Buy |
844
+14
| +2% | +$382 | 0.01% | 938 |
|
|
2014
Q4 | $21K | Sell |
830
-1,758
| -68% | -$44.5K | 0.01% | 960 |
|
|
2014
Q3 | $57K | Buy |
2,588
+2,078
| +407% | +$45.8K | 0.01% | 878 |
|
|
2014
Q2 | $11K | Buy |
+510
| New | +$11K | 0.01% | 765 |
|